BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2316454)

  • 1. Influence of ventricular function and presence or absence of coronary artery disease on results of electrophysiologic testing for asymptomatic nonsustained ventricular tachycardia.
    Hammill SC; Trusty JM; Wood DL; Bailey KR; Vatterott PJ; Osborn MJ; Holmes DR; Gersh BJ
    Am J Cardiol; 1990 Mar; 65(11):722-8. PubMed ID: 2316454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk stratification and management of patients with organic heart disease and nonsustained ventricular tachycardia: role of programmed stimulation, left ventricular ejection fraction, and the signal-averaged electrocardiogram.
    Turitto G; Fontaine JM; Ursell S; Caref EB; Bekheit S; el-Sherif N
    Am J Med; 1990 Jan; 88(1N):35N-41N. PubMed ID: 2368762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of electrophysiologic testing in patients with previous myocardial infarction and nonsustained ventricular tachycardia. Philadelphia Arrhythmia Group.
    Kowey PR; Waxman HL; Greenspon A; Greenberg R; Poll D; Kutalek S; Gessman L; Muenz L
    Am J Cardiol; 1990 Mar; 65(9):594-8. PubMed ID: 2309629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonsustained ventricular tachycardia in patients with coronary artery disease: role of electrophysiologic study.
    Buxton AE; Marchlinski FE; Flores BT; Miller JM; Doherty JU; Josephson ME
    Circulation; 1987 Jun; 75(6):1178-85. PubMed ID: 3568327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of sustained ventricular tachycardia inducibility in patients with nonsustained ventricular tachycardia and chronic coronary artery disease.
    Furukawa T; Rozanski JJ; Moroe K; Gosselin AJ; Lister JW
    Am Heart J; 1989 May; 117(5):1050-9. PubMed ID: 2711964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of programmed ventricular stimulation in the evaluation and management of patients with nonsustained ventricular tachycardia associated with coronary artery disease.
    Manolis AS; Estes NA
    Am J Cardiol; 1990 Jan; 65(3):201-5. PubMed ID: 2296889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiographic and electrophysiologic substrates of ventricular tachycardia in chronic Chagasic myocarditis.
    de Paola AA; Horowitz LN; Miyamoto MH; Pinheiro R; Ferreira DF; Terzian AB; Cirenza C; Guiguer N; Portugal OP
    Am J Cardiol; 1990 Feb; 65(5):360-3. PubMed ID: 2301265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of signal-averaged electrocardiographic criteria with Frank XYZ leads and spectral filter used alone and in combination with ejection fraction to predict inducible ventricular tachycardia in coronary artery disease.
    Hammill SC; Tchou PJ; Kienzle MG; Haisty WK; Ozawa Y; Underwood DA
    Am J Cardiol; 1992 Aug; 70(3):316-20. PubMed ID: 1632395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of electrophysiologic testing in patients with nonsustained ventricular tachycardia.
    Sulpizi AM; Friehling TD; Kowey PR
    Am J Cardiol; 1987 Apr; 59(8):841-5. PubMed ID: 3825947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproducibility of programmed electrical stimulation responses in patients with ventricular tachycardia or fibrillation associated with coronary artery disease.
    Volgman AS; Zheutlin TA; Mattioni TA; Parker MA; Kehoe RF
    Am J Cardiol; 1992 Sep; 70(7):758-63. PubMed ID: 1519526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Programmed ventricular stimulation in coronary artery disease and dilated cardiomyopathy: influence of the underlying heart disease on the results of electrophysiologic testing.
    Gonska BD; Bethge KP; Kreuzer H
    Clin Cardiol; 1987 May; 10(5):294-304. PubMed ID: 3594942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective comparison of a conventional and an accelerated protocol for programmed ventricular stimulation in patients with coronary artery disease.
    Morady F; Kadish A; de Buitleir M; Kou WH; Calkins H; Schmaltz S; Rosenheck S; Sousa J
    Circulation; 1991 Mar; 83(3):764-73. PubMed ID: 1999027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiologic testing in patients at high risk for sudden cardiac death. I. Nonsustained ventricular tachycardia and abnormal ventricular function.
    Spielman SR; Greenspan AM; Kay HR; Discigil KF; Webb CR; Sokoloff NM; Rae AP; Morganroth J; Horowitz LN
    J Am Coll Cardiol; 1985 Jul; 6(1):31-40. PubMed ID: 4008786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of late arrhythmic events after acute myocardial infarction from combined use of noninvasive prognostic variables and inducibility of sustained monomorphic ventricular tachycardia.
    Pedretti R; Etro MD; Laporta A; Sarzi Braga S; Carù B
    Am J Cardiol; 1993 May; 71(13):1131-41. PubMed ID: 8480637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of extrastimulus prematurity and intraventricular conduction time in inducing ventricular tachycardia or ventricular fibrillation secondary to coronary artery disease.
    Gillis AM; Winkle RA; Echt DS
    Am J Cardiol; 1987 Sep; 60(7):590-5. PubMed ID: 3630942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of sustained into nonsustained ventricular tachycardia during therapy assessment by programmed ventricular stimulation: criterion for a positive drug effect?
    Schoels W; Brachmann J; Schmitt C; Waldecker B; Kuebler W
    Am J Cardiol; 1989 Aug; 64(5):329-34. PubMed ID: 2756877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of nonsustained ventricular tachycardia guided by electrophysiological testing.
    Kadish A; Schmaltz S; Calkins H; Morady F
    Pacing Clin Electrophysiol; 1993 May; 16(5 Pt 1):1037-50. PubMed ID: 7685883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Right ventricular dysfunction predisposes to inducible ventricular tachycardia at electrophysiology studies in patients with acute ST-segment-elevation myocardial infarction and reduced left ventricular ejection fraction.
    Thakkar JB; Zaman S; Byth K; Narayan A; Thiagalingam A; Chow C; Thomas SP; Sivagangabalan G; Farlow D; Barnett R; Kovoor P
    Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):898-905. PubMed ID: 25108742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
    Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN
    Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonsustained ventricular tachycardia in coronary artery disease: relation to inducible sustained ventricular tachycardia. MUSTT Investigators.
    Buxton AE; Lee KL; DiCarlo L; Echt DS; Fisher JD; Greer GS; Josephson ME; Packer D; Prystowsky EN; Talajíc M
    Ann Intern Med; 1996 Jul; 125(1):35-9. PubMed ID: 8644986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.